Neuronal surface glycolytic enzymes are autoantigen targets in post-streptococcal autoimmune CNS disease.
Infection with the Group A Streptococcus (GAS) can result in immune mediated brain disease characterised by a spectrum of movement and psychiatric disorders. We have previously described anti-neuronal antibodies in patients that bind to a restricted group of brain antigens with molecular weights 40...
Main Authors: | Dale, R, Candler, P, Church, A, Wait, R, Pocock, J, Giovannoni, G |
---|---|
Format: | Journal article |
Language: | English |
Published: |
2006
|
Similar Items
-
Post-streptococcal opsoclonus-myoclonus syndrome associated with anti-neuroleukin antibodies.
by: Candler, P, et al.
Published: (2006) -
Interferon and autoantigens: intersection in autoimmunity
by: Brendan Antiochos, et al.
Published: (2023-05-01) -
Impact of Autoantibodies against Glycolytic Enzymes on Pathogenicity of Autoimmune Retinopathy and Other Autoimmune Disorders
by: Grazyna Adamus
Published: (2017-04-01) -
Identification of endothelin-converting enzyme-2 as an autoantigen in autoimmune polyendocrine syndrome type 1
by: Casey J. A. Smith-Anttila, et al.
Published: (2017-05-01) -
Immunoproteomics technologies in the discovery of autoantigens in autoimmune diseases
by: Ganesan Vinitha, et al.
Published: (2016-05-01)